GLUT-1 in oral benign vascular lesions.

AIM To investigate the accuracy of histological diagnosis of oral hemangioma, oral vascular malformation and oral pyogenic granuloma according to immunohistochemical evaluation of the human erythrocyte-type glucose transporter protein (GLUT-1), and to observe the immunoexpression of this protein in oral varix. MATERIALS AND METHODS Immunohistochemistry for GLUT-1 was performed in 93 histologically diagnosed cases of oral benign vascular lesions: 17 vascular malformations, 19 hemangiomas, nine varix, and 48 pyogenic granulomas. Descriptive analyses were performed. RESULTS None of the cases of the oral benign vascular lesions evaluated were immunopositive to GLUT-1. The 19 cases histologically diagnosed as oral hemangioma that showed negative staining to GLUT-1 were reclassified as oral pyogenic granuloma or oral vascular malformations. The histological evaluation itself is not enough to obtain the correct diagnosis of oral HEM as none of the sample cases were true hemangioma. All sample cases with initial vascular malformation or pyogenic granulomas classification were negative to GLUT-1, demonstrating the accuracy of histological diagnosis of these lesions itself. Oral varix showed negative staining to GLUT-1 in blood vessels. CONCLUSIONS GLUT-1 is an useful, effective and important auxiliary marker for the diagnosis of oral benign vascular lesions. CLINICAL RELEVANCE This study showed that histological diagnosis alone is not sufficient to correct diagnoses of oral hemangioma. Moreover, immunohistochemistry to GLUT-1 is a useful and easy diagnostic method that may be used to avoid such misdiagnosis. Accurate diagnosis of these oral lesions has an important clinical relevance allowing: (1) correct management, (2) adequate communication among the multidisciplinary team (dentist, dermatologist, pediatrist, radiologist, pathologist, and surgeon), (3) understanding of the biological behavior of the lesions, and (4) facilitate the development of new therapeutic modalities. Thus, supporting the use of this marker in medical and dentistry communities is warranted.

[1]  J. Bouquot,et al.  Oral & maxillofacial pathology / , 2009 .

[2]  A. Epivatianos,et al.  Pyogenic granuloma of the oral cavity: Comparative study of its clinicopathological and immunohistochemical features , 2005, Pathology international.

[3]  J. Encinas,et al.  The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. , 2005, Journal of pediatric surgery.

[4]  J. Leon-Villapalos,et al.  GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. , 2005, British journal of plastic surgery.

[5]  R. Drut,et al.  Extracutaneous infantile haemangioma is also Glut1 positive , 2004, Journal of Clinical Pathology.

[6]  N. Sepp,et al.  Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. , 2004, Human pathology.

[7]  J. Mulliken,et al.  Congenital hemangiomas and infantile hemangioma: missing links. , 2004, Journal of the American Academy of Dermatology.

[8]  K. Bove,et al.  GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. , 2004, Human pathology.

[9]  K. Ababneh,et al.  Oral pyogenic granuloma in Jordanians: a retrospective analysis of 108 cases. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[10]  J. Mulliken,et al.  Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[11]  H. Freeze,et al.  GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. , 2002, Genomics.

[12]  M. Mihm,et al.  Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. , 2001, Archives of dermatology.

[13]  J. Mulliken,et al.  Molecular genetics of vascular malformations. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[14]  M. Mihm,et al.  A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. , 2001, Archives of dermatology.

[15]  M. Mihm,et al.  GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. , 2000, Human pathology.

[16]  Rodney T. Miller,et al.  Blocking of Endogenous Avidin-Binding Activity in Immunohistochemistry: The Use of Skim Milk as an Economical and Effective Substitute for Commercial Biotin Solutions , 1999 .

[17]  Mark A. Stephenson,et al.  Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival , 1997, Cancer.

[18]  J. Mulliken,et al.  Vascular tumors and vascular malformations (new issues). , 1997, Advances in dermatology.

[19]  J. Glowacki,et al.  Congenital vascular lesions: clinical application of a new classification. , 1983, Journal of pediatric surgery.

[20]  J. Glowacki,et al.  Hemangiomas and Vascular Malformations in Infants and Children: A Classification Based on Endothelial Characteristics , 1982, Plastic and reconstructive surgery.

[21]  J. C. Southam,et al.  A histologic study of sublingual varices. , 1974, Oral surgery, oral medicine, and oral pathology.